// App-Quantinova.ai

P934 : DARATUMUMAB + LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: A POST HOC ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY FROM GRIFFIN

Researchers

Presenter

  • Cesar Rodriguez

Principal Investigators

  • Jacob Laubach

  • Douglas W. Sborov

  • Brandi Reeves

  • Ajai Chari

  • Rebecca Silbermann

  • Luciano J. Costa

  • Larry D. Anderson Jr

  • Nitya Nathwani

  • Nina Shah

  • Naresh Bumma

  • Andrzej Jakubowiak

  • Robert Z. Orlowski

  • Huiling Pei

  • Annelore Cortoos

  • Sharmila Patel

  • Thomas S. Lin

  • Paul G. Richardson

  • Peter M. Voorhees

Medical Centers

  • Science University,Portland,Stati Uniti

  • Huntsman Cancer Institute, UT.

  • Dana-Farber Cancer Institute Boston,Boston,Stati Uniti

  • The University of Chicago Medical Center,Chicago,Vereinigte Staaten

  • Dana-Farber Cancer Institute, Boston, MA, United States

  • Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • Tisch Cancer Institute, Mount Sinai School of Medicine,New York City,Vereinigte Staaten

  • University of North Carolina at Chapel Hill,Chapel Hill,Estados Unidos

  • Wake Forest University School of Medicine, Winston-Salem, United States

  • Tisch Cancer Center, Mount Sinai School of Medicine, New York, NY

  • Science University (OHSU),Portland,Vereinigte Staaten

  • Dana-Farber Cancer Institute, Boston, MA

  • Winship Cancer Institute of Emory University,Atlanta, GA,Vereinigte Staaten

  • Wake Forest University School of Medicine, Winston-Salem, United States

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Janssen Scientific Affairs, LLC,Horsham,États-unis

  • Simmons Comprehensive Cancer Center, UT Southwestern Medical Center,Dallas,États-unis

  • Simmons Comprehensive Cancer Center, UT Sout

  • Department of Medicine, University of Toronto

  • Hematology,Ohio State University Comprehensive Cancer Center,Columbus,États-unis

  • Huntsman Cancer Institute, University of Utah School of Medicine,Salt Lake City,Vereinigte Staaten

  • Winship Cancer Institute of Emory University,Atlanta, GA,Vereinigte Staaten

  • Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States

  • Huntsman Cancer Institute, University of Utah School of Medicine,Salt Lake City,Vereinigte Staaten

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • Dana-Farber Cancer Institute Boston,Boston,Stati Uniti

  • Tisch Can

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Neurology,University of Alabama at Birmingham,Birmingham, AL,Vereinigte Staaten

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Winship Cancer Institute of Emory University,Atlanta, GA,Vereinigte Staaten

  • Janssen Research &amp

  • Development, LLC,Titusville

  • University of Alabama at...

  • University of North Carolina, Chapel Hill, NC

  • Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX

  • Development, LLC,Titusville, NJ,Stati Uniti

  • Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, La Verne, CA

  • The University of Chicago Medical Center, Chicago, IL

  • University of Alabama at Birmingham, Birmingham, AL

  • Department of Lymphoma and Myeloma,The University of Texas MD Ander

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • University of Alabama at Birmingham, Birmingham, AL

  • Hematology,Huntsman Cancer Institute, University of Utah,Salt Lake City,États-unis

  • Winshi

  • University of North Carolina, Chapel Hill, NC

  • Science University, Portland, Oregon, United States

  • Simmons Comprehensive Cancer Center, UT Southwestern Medical Center,Dallas,États-unis

  • Wake Forest University School of Medicine, Winston-Salem, United States

  • Janssen Scientifi

  • University of North Carolina, Chapel Hill, NC

  • Tisch Cancer Institute, Mount Sinai School of Medicine,New York City,Vereinigte Staaten

  • University of North Carolina at Chapel Hill, Chapel Hill, NC, United States

  • University of Alabama at Birmingham, Birmingham, AL

  • Development, LLC,Titusville, NJ,Stati Uniti

  • University of North Carolina – Chapel Hill,Chapel Hill,Vereinigte Staaten

  • Tisch Cancer Institute, Mount Sinai School of Medicine,New York City,Vereinigte Staaten

  • Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX

  • Wake Forest University School of Medicine

  • Levine Cancer Institute, Atrium Health,Charlotte,Verenigde Staten

  • Huntsman Cancer Hospital, University of Utah School of Medicine, Salt Lake City, UT

  • Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX

  • Neurology,University of Alabama at Birmingham,Birmingham, AL,Vereinigte Staaten

  • Development, IHI RWE,Titusville, NJ,United States

  • Dana-Farber Cancer Institute Boston,Boston,Stati Uniti

  • Levine Cancer Institute, Atrium Health,Charlotte,Verenigde Staten

  • The University of Chicago Medical Center,Chicago,Vereinigte Staaten

  • Janssen Scientific Affairs, LLC,Horsham,Vereinigte Staaten

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Dana-Faber Cancer Institute,Boston,Verenigde Staten

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Dana-Faber Cancer Institute,Boston,Verenigde Staten

  • Development,Titusville, NJ,Vereinigte Staaten

  • Janssen Scientific Affairs, LLC,Horsham,Vereinigte Staaten

  • Tisch Cancer Institute, Mount Sinai School of Medicine,New York City,Vereinigte Staaten

  • Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, La Verne, CA

  • Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, La Verne, CA

  • Wake Forest University School of Medicine, Winston-Salem, United States

  • Levine Cancer Institute, Atrium Health,Charlotte,Estados Unidos

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Janssen Scientific Affairs, LLC,Horsham,États-unis

  • Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, United States

  • Knight Cancer Institute, Oregon Heal

  • Development,Titusville,Estados Unidos

  • Rush University Medical Center, Chicago, Illinois, United States

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • Knight Cancer Institute, Oregon Heal

  • University of Alabama at Birmingham, Birmingham, AL

  • Wake Forest University School of Medicine, Winston-Salem, United States

  • Judy and Bernard Briskin

  • Janssen Scientific Affairs, LLC,Horsham,États-unis

  • Science University,Portland,États-unis

  • Levine Cancer Inst

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • daratumumab Intravenous

  • Bortezomib

  • Sparsentan

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved